This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.

HCV2021 Program

VIRTUAL PLATFORM ACCESS

Click Here to access the HCV Virtual Platform.

Reach out to HCVregistration@mci-group.com for any assistance with logging in.


All times are in Eastern Daylight Time (EDT) / (GMT - 4:00)

*Program & Topics/Titles are Subject to Change 

Friday, July 9, 2021

  • 10:00 13:15

    Session 10: Vaccines

    Co-chairs: Chris Walker & Ellie Barnes

    10:00 - 10:30 | Plenary Lecture 8: Systems Biology to Predict Vaccine Efficacy
                               Rafick Sekaly - Pathology Advanced Translational Research Unit (PATRU) | Emory University, Atlanta, GA, USA

    10:30 - 11:00 | Keynote Lecture 11: Update on Immunological Analysis of HCV Vaccine Trial
                               Andrea Cox - Johns Hopkins School of Medicine, Baltimore, MD, USA

    10:55 - 12:00 | Panel Discussion on the Future of Vaccine Development for HCV
                               Justin Bailey - Johns Hopkins University School of Medicine
                               Ellie Barnes - University of Oxford, UK
                               Andrea Cox - Johns Hopkins School of Medicine, Baltimore, MD, USA
                               Jake Liang - National Institute of Health, Bethesda, USA
                               Rafick Sekaly - Emory University School of Medicine,USA
                               Chris Walker - Ohio State University, USA
                               Thomas Pietschmann - TWINCORE - Centre for Experimental and Clinical Infection Research, Germany

  • 12:00 12:30

    Break

  • 12:30 13:15

    Oral Presentations selected from Abstracts

    Co-chairs: Steven Foung & Barbara Rehermann

    12:30 - 12:45 | Functional convergence of a germline-encoded broadly neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
                               Fang Chen, The Scripps Research Institute, United States

    12:45 - 13:00 | Structural studies of HCV E2 envelope glycoprotein that facilitates rational design of HCV vaccine.
                               Netanel Tzarum, The Hebrew University Of Jerusalem, Israel

    13:00 - 13:15 | An antigenically diverse, representative panel of HCV envelope glycoproteins for standardized neutralization assays
                               Jordan Hector Salas, Johns Hopkins University, United States

  • 13:15 13:45

    Closing Lecture: HCV, the Next 30 Years

    Michael Houghton - University of Alberta, Edmonton, AB, Canada

  • 13:45 14:00

    Awards Ceremony & Closing Remarks

    Daniel Lamarre - DiuTinus ImmunoTherapeutics Inc, Cleveland, OH, USA

    Brett Lindebach - Yale School of Medicine, New Haven, CT, USA

  • 14:00 14:15

    HCV 2022 Presentation

    Philip Meuleman